share_log

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  May 2 15:30
Summary by Moomoo AI
Arcutis Biotherapeutics, Inc. officer Matsuda Masaru is set to sell 5,016 shares of common stock on 05/02/2024, as per the latest filing. The shares, valued at an aggregate market price of $43,828, were acquired on 05/01/2024 through a restricted stock vest from Arcutis Biotherapeutics. This transaction follows a previous sale of 3,760 shares by Matsuda in the past three months, which had gross proceeds of $41,815.
Arcutis Biotherapeutics, Inc. officer Matsuda Masaru is set to sell 5,016 shares of common stock on 05/02/2024, as per the latest filing. The shares, valued at an aggregate market price of $43,828, were acquired on 05/01/2024 through a restricted stock vest from Arcutis Biotherapeutics. This transaction follows a previous sale of 3,760 shares by Matsuda in the past three months, which had gross proceeds of $41,815.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more